Conclusion
the dossier summarised in one paragraphThe computed 12-month bankruptcy probability of BelCoPhar is 2.2% (average). The company has been active since 2022 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Financials
No processed annual-account figures available.
To financials
People & board
No director data processed yet.
To directors Publications
No State Gazette publications linked.
To publications Network & structure
No network or structure data processed.
To structure
Trust signals
3 signalsMore than 3 years active
Founded in 2022 — past the statistically most fragile first 3 years.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad.
Administratively compliant
No FOD Economie strikeouts (UBO, accounts, address, activity).
Administrative Flags
0 events
No administrative flags
Bankruptcy probability (12 mo)
Checked model v1 · free for everyone2.2%
Average
0%0,5%1,5%4%10%≥25%
Young company
+Multiple establishment units
+Higher-failure-rate sector
+
Statistical estimate based on public sources — not credit advice nor a finding of fact. How do we compute this?
Company registry (CBE)
Crossroads BankActivities
Vervaardiging van geneesmiddelen21201Vervaardiging van geneesmiddelen21201Vervaardiging van farmaceutische grondstoffen21100Vervaardiging van farmaceutische grondstoffen21100Vervaardiging van overige farmaceutische producten21209Vervaardiging van overige farmaceutische producten21209
Primary activity highlighted.
Names & trade names
| Legal nameNL | BelCoPhar |
Registered office
Heiken (Ab) 5
2920 Kalmthout, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.